690 related articles for article (PubMed ID: 29920338)
1. Reoperative central lymph node dissection for incidental papillary thyroid cancer can be performed safely: A retrospective review.
Hall CM; LaSeur DC; Snyder SK; Lairmore TC
Int J Surg; 2018 Aug; 56():102-107. PubMed ID: 29920338
[TBL] [Abstract][Full Text] [Related]
2. Routine central lymph node dissection with total thyroidectomy for papillary thyroid cancer potentially minimizes level VI recurrence.
Hall CM; Snyder SK; Maldonado YM; Lairmore TC
Surgery; 2016 Oct; 160(4):1049-1058. PubMed ID: 27521047
[TBL] [Abstract][Full Text] [Related]
3. Central Lymph Node Dissection Improves Lymph Node Clearance in Papillary Thyroid Cancer Patients with Lateral Neck Metastases, Even after Prior Total Thyroidectomy.
Hall CM; Snyder SK; Lairmore TC
Am Surg; 2018 Apr; 84(4):531-536. PubMed ID: 29712601
[TBL] [Abstract][Full Text] [Related]
4. Central neck lymph node dissection for papillary thyroid cancer: comparison of complication and recurrence rates in 295 initial dissections and reoperations.
Shen WT; Ogawa L; Ruan D; Suh I; Kebebew E; Duh QY; Clark OH
Arch Surg; 2010 Mar; 145(3):272-5. PubMed ID: 20231628
[TBL] [Abstract][Full Text] [Related]
5. Rationality in prophylactic central neck dissection in clinically node-negative (cN0) papillary thyroid carcinoma: Is there anything more to say? A decade experience in a single-center.
Dobrinja C; Troian M; Cipolat Mis T; Rebez G; Bernardi S; Fabris B; Piscopello L; Makovac P; Di Gregorio F; de Manzini N
Int J Surg; 2017 May; 41 Suppl 1():S40-S47. PubMed ID: 28506412
[TBL] [Abstract][Full Text] [Related]
6. Central lymph node dissection as a secondary procedure for papillary thyroid cancer: Is there added morbidity?
Alvarado R; Sywak MS; Delbridge L; Sidhu SB
Surgery; 2009 May; 145(5):514-8. PubMed ID: 19375610
[TBL] [Abstract][Full Text] [Related]
7. Level VI lymph node dissection for papillary thyroid cancer.
White ML; Doherty GM
Minerva Chir; 2007 Oct; 62(5):383-93. PubMed ID: 17947949
[TBL] [Abstract][Full Text] [Related]
8. Complications of central neck dissection in patients with papillary thyroid carcinoma: results of a study on 1087 patients and review of the literature.
Giordano D; Valcavi R; Thompson GB; Pedroni C; Renna L; Gradoni P; Barbieri V
Thyroid; 2012 Sep; 22(9):911-7. PubMed ID: 22827494
[TBL] [Abstract][Full Text] [Related]
9. Routine bilateral central lymph node clearance for papillary thyroid cancer.
Sadowski BM; Snyder SK; Lairmore TC
Surgery; 2009 Oct; 146(4):696-703; discussion 703-5. PubMed ID: 19789029
[TBL] [Abstract][Full Text] [Related]
10. Timing and extension of lymphadenectomy in medullary thyroid carcinoma: A case series from a single institution.
Polistena A; Sanguinetti A; Lucchini R; Galasse S; Monacelli M; Avenia S; Boccolini A; Johnson LB; Avenia N
Int J Surg; 2017 May; 41 Suppl 1():S70-S74. PubMed ID: 28506418
[TBL] [Abstract][Full Text] [Related]
11. Level VII is an important component of central neck dissection for papillary thyroid cancer.
Wang LY; Versnick MA; Gill AJ; Lee JC; Sidhu SB; Sywak MS; Delbridge LW
Ann Surg Oncol; 2013 Jul; 20(7):2261-5. PubMed ID: 23361896
[TBL] [Abstract][Full Text] [Related]
12. Central lymph node dissection in differentiated thyroid cancer.
White ML; Gauger PG; Doherty GM
World J Surg; 2007 May; 31(5):895-904. PubMed ID: 17347896
[TBL] [Abstract][Full Text] [Related]
13. Prophylactic central lymph node dissection for clinically node-negative papillary thyroid microcarcinoma: influence on serum thyroglobulin level, recurrence rate, and postoperative complications.
So YK; Seo MY; Son YI
Surgery; 2012 Feb; 151(2):192-8. PubMed ID: 21497873
[TBL] [Abstract][Full Text] [Related]
14. Central lymph node dissection and permanent hypoparathyroidism after total thyroidectomy for papillary thyroid cancer: population-based study.
Salem FA; Bergenfelz A; Nordenström E; Almquist M
Br J Surg; 2021 Jun; 108(6):684-690. PubMed ID: 34157088
[TBL] [Abstract][Full Text] [Related]
15. Clinical Efficacy of Intraoperative Ultrasound for Prophylactic Lymphadenectomy of the Lateral Cervical Neck in Stage CN0 Papillary Thyroid Cancer: A Prospective Study.
Shen Y; Li X; Tao L; Chen Y; Xie R
J Invest Surg; 2023 Dec; 36(1):2154416. PubMed ID: 36519315
[No Abstract] [Full Text] [Related]
16. Morbidity following central compartment reoperation for recurrent or persistent thyroid cancer.
Kim MK; Mandel SH; Baloch Z; Livolsi VA; Langer JE; Didonato L; Fish S; Weber RS
Arch Otolaryngol Head Neck Surg; 2004 Oct; 130(10):1214-6. PubMed ID: 15492172
[TBL] [Abstract][Full Text] [Related]
17. Differentiated thyroid cancer: role of the lymph node dissection.
Caglià P; Zappulla E; Costa S; Tracia M; Veroux M; Russo V; Borzì L; Lucifora B; Patanè G; Tracia L; Amodeo C
G Chir; 2010; 31(6-7):293-5. PubMed ID: 20646374
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of central lymph node dissection for papillary thyroid carcinoma in cN0 T1/T2].
Zhao SY; Ma YH; Yin Z; Zhan XX; Cheng RC; Qian J
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 Feb; 53(2):105-109. PubMed ID: 29429179
[No Abstract] [Full Text] [Related]
19. Right Central Lymph Node Dissection in Thyroidectomy: Can Endoscopic Chest-Breast Approach Be Used?
Sun P; Chen W; Mak TK; Chong TH; Li J; Yang J; Wang C
J Laparoendosc Adv Surg Tech A; 2020 Mar; 30(3):308-314. PubMed ID: 31746665
[No Abstract] [Full Text] [Related]
20. Short and Long-Term Potential Role of Carbon Nanoparticles in Total Thyroidectomy with Central Lymph Node Dissection.
Xue S; Ren P; Wang P; Chen G
Sci Rep; 2018 Aug; 8(1):11936. PubMed ID: 30093623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
